NCT05237947View on ClinicalTrials.gov

Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

5,000

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Human Papillomavirus-Related Cervical Carcinoma
Interventions
BIOLOGICAL

Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed

Given IM

OTHER

Questionnaire Administration

Ancillary studies

BIOLOGICAL

Recombinant Human Papillomavirus Bivalent Vaccine

Given IM

BIOLOGICAL

Recombinant Human Papillomavirus Nonavalent Vaccine

Given IM

Trial Locations (1)

50101

Agencia Costarricense de Investigaciones Biomédicas (ACIB), Liberia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH